1-3 of 3
Pär Josefsson, MD PhD
Close
Sort by
Journal Articles

Lymphoma Patients Treated without Anthracyclines Have Negligible Risk of Cardiotoxicity: A Nationwide Cohort Study

Joachim Baech, Steen Moeller Hansen, Peter Enemark Lund, Christian Torp-Pedersen, Peter Soegaard, Peter de Nully Brown, MD PhD, Henrik Frederiksen, Judit Mészáros Jørgensen, Joern Starklint, Pär Josefsson, MD PhD, Christian Bjørn Poulsen, Hans Erik Johnsen, MD Professor, Tarec Christoffer El-Galaly, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2843.
https://doi.org/10.1182/blood.V130.Suppl_1.2843.2843
Published: 2017
Journal Articles

The Impact of Pre-Therapeutic Haemoglobin Levels on the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline Containing Chemotherapy before and after the Introduction of Rituximab: A Nation-Wide Cohort Study

Michael Roost Clausen, MD, Sinna Pilgaard Ulrichsen, MSc, Thomas Stauffer Larsen, MD PhD, Bodil Himmelstrup, MD PhD, Dorthe Rønnov-Jessen, MD, Per Trøllund Pedersen, MD, Jakob Madsen, MD, Robert Schou Pedersen, MD, Pär Josefsson, MD PhD, Jette Sønderskov Gørløv, MD, Mette Nørgaard, MD PhD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1566.
https://doi.org/10.1182/blood.V130.Suppl_1.1566.1566
Published: 2017
Journal Articles

Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma

Adam Vilmar, PhD MD, Bente Arboe, Par Josefsson, MD PhD, Christian Poulsen, Jacob Haaber Christensen, Judit Jørgensen, MD PhD, Paw Jensen, Jørn Starklint, Per Troellund Pedersen, Michael Pedersen, Peter de Nully Brown, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1781.
https://doi.org/10.1182/blood.V128.22.1781.1781
Published: 2016